The Polycomb group protein EZH2 directly controls DNA methylation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The establishment and maintenance of epigenetic gene silencing is fundamental to cell determination and function. The essential epigenetic systems involved in heritable repression of gene activity are the Polycomb group (PcG) proteins and the DNA methylation systems. Here we show that the corresponding silencing pathways are mechanistically linked. We find that the PcG protein EZH2 (Enhancer of Zeste homolog 2) interacts-within the context of the Polycomb repressive complexes 2 and 3 (PRC2/3)-with DNA methyltransferases (DNMTs) and associates with DNMT activity in vivo. Chromatin immunoprecipitations indicate that binding of DNMTs to several EZH2-repressed genes depends on the presence of EZH2. Furthermore, we show by bisulphite genomic sequencing that EZH2 is required for DNA methylation of EZH2-target promoters. Our results suggest that EZH2 serves as a recruitment platform for DNA methyltransferases, thus highlighting a previously unrecognized direct connection between two key epigenetic repression systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neither did Dnmt3a, another chromatin modifying enzyme that is a PRC2 component and is frequently genetically inactivated in myeloid neoplasms (Fig. 5) (31”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [32]
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex
Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A., Wild, B., Miller, E. L., O'Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,562
Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,533
Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase
Jackson, J. P., Lindroth, A. M., Cao, X., & Jacobsen, S. E. (2002) · Nature · doi:10.1038/nature731 · Cited by 1,251
Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,245
Role of Histone H3 Lysine 27 Methylation in X Inactivation
Plath, K., Fang, J., Mlynarczyk-Evans, S. K., Cao, R., Worringer, K. A., Wang, H., de la Cruz, C. C., Otte, A. P., Panning, B., & Zhang, Y. (2003) · Science · doi:10.1126/science.1084274 · Cited by 1,195
Cited by
Items 301–400 of 1,004
Identification of Driver and Passenger DNA Methylation in Cancer by Epigenomic Analysis
Kalari, S., & Pfeifer, G. P. (2010) · Advances in Genetics · doi:10.1016/b978-0-12-380866-0.60010-1 · Cited by 144
Epigenetic regulation of epithelial–mesenchymal transition
Sun, L., & Fang, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2303-1 · Cited by 160
FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury
Chang-Panesso, M., Kadyrov, F. F., Lalli, M., Wu, H., Ikeda, S., Kefaloyianni, E., Abdelmageed, M. M., Herrlich, A., Kobayashi, A., & Humphreys, B. D. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125519 · Cited by 158
“Ezh2 belongs to the polycomb repressive complex 2 (PRC2), which participates in methylation of histone 3 (H3K27me), leading to transcriptional repression (37, 38).”
BackgroundDevelopmental reprogramming of cancer susceptibility
Walker, C. L., & Ho, S.-M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3220 · Cited by 158
Wang, L., Zhang, X., Jia, L.-T., Hu, S.-J., Zhao, J., Yang, J.-D., Wen, W.-H., Wang, Z., Wang, T., Zhao, J., et al. (2014) · Hepatology · doi:10.1002/hep.26720 · Cited by 158
EZH2 Y641 mutations in follicular lymphoma
Bödör, C., Ó’Riain, C., Wrench, D., Matthews, J., Iyengar, S., Tayyib, H., Calaminici, M., Clear, A. J., Iqbal, S., Quentmeier, H., et al. (2011) · Leukemia · doi:10.1038/leu.2010.311 · Cited by 158
Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location!
van Vlodrop, I. J. H., Niessen, H. E. C., Derks, S., Baldewijns, M. M. L. L., van Criekinge, W., Herman, J. G., & van Engeland, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3394 · Cited by 144
Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG
Cordero, F. J., Huang, Z., Grenier, C., He, X., Hu, G., McLendon, R. E., Murphy, S. K., Hashizume, R., & Becher, O. J. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0389 · Cited by 157
Gebhard, C., Benner, C., Ehrich, M., Schwarzfischer, L., Schilling, E., Klug, M., Dietmaier, W., Thiede, C., Holler, E., Andreesen, R., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3406 · Cited by 125
Intracellular and extracellular TGF-β signaling in cancer: some recent topics
Miyazono, K., Katsuno, Y., Koinuma, D., Ehata, S., & Morikawa, M. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0646-8 · Cited by 140
RNA–protein interactions: disorder, moonlighting and junk contribute to eukaryotic complexity
Balcerak, A., Trebinska-Stryjewska, A., Konopinski, R., Wakula, M., & Grzybowska, E. A. (2019) · Open Biology · doi:10.1098/rsob.190096 · Cited by 151
Antagonism between DNA and H3K27 Methylation at the Imprinted Rasgrf1 Locus
Lindroth, A. M., Park, Y. J., McLean, C. M., Dokshin, G. A., Persson, J. M., Herman, H., Pasini, D., Miró, X., Donohoe, M. E., Lee, J. T., et al. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000145 · Cited by 121
Morris, A. P., Le, T. H., Wu, H., Akbarov, A., van der Most, P. J., Hemani, G., Smith, G. D., Mahajan, A., Gaulton, K. J., Nadkarni, G. N., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07867-7 · Cited by 145
Rauluševičiūtė, I., Drabløs, F., & Rye, M. B. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0657-6 · Cited by 157
Cellular memory and dynamic regulation of polycomb group proteins
Bantignies, F., & Cavalli, G. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.04.003 · Cited by 154
Li, Y., Gan, Y., Liu, J., Li, J., Zhou, Z., Tian, R., Sun, R., Liu, J., Xiao, Q., Li, Y., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00902-6 · Cited by 153
Hayashi, Y., Tsujii, M., Wang, J., Kondo, J., Akasaka, T., Jin, Y., Li, W., Nakamura, T., Nishida, T., Iijima, H., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301625 · Cited by 144
The impact of epigenetics on cardiovascular disease
Prasher, D., Greenway, S. C., & Singh, R. B. (2019) · Biochemistry and Cell Biology · doi:10.1139/bcb-2019-0045 · Cited by 153
Yang, Q.-Y., Liang, J.-F., Rogers, C. J., Zhao, J.-X., Zhu, M.-J., & Du, M. (2013) · Diabetes · doi:10.2337/db13-0433 · Cited by 152
Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis
Wang, Y., & Shang, Y. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.07.019 · Cited by 153
Wagener, N., Macher-Goeppinger, S., Pritsch, M., Hüsing, J., Hoppe-Seyler, K., Schirmacher, P., Pfitzenmaier, J., Haferkamp, A., Hoppe-Seyler, F., & Hohenfellner, M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-524 · Cited by 142
Börno, S. T., Fischer, A., Kerick, M., Fälth, M., Laible, M., Brase, J. C., Kuner, R., Dahl, A., Grimm, C., Sayanjali, B., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0041 · Cited by 151
Acharyya, S., Sharma, S. M., Cheng, A. S., Ladner, K. J., He, W., Kline, W., Wang, H., Ostrowski, M. C., Huang, T. H., & Guttridge, D. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012479 · Cited by 136
Mutator pathways unleashed by epigenetic silencing in human cancer
Jacinto, F. V., & Esteller, M. (2007) · Mutagenesis · doi:10.1093/mutage/gem009 · Cited by 153
Self-citationDekel, B., Metsuyanim, S., Schmidt-Ott, K. M., Fridman, E., Jacob–Hirsch, J., Simon, A. J., Pinthus, J. H., Mor, Y., Barasch, J. M., Amariglio, N., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4528 · Cited by 151
Epigenetics: Judge, jury and executioner of stem cell fate
Tollervey, J. R., & Lunyak, V. V. (2012) · Epigenetics · doi:10.4161/epi.21141 · Cited by 113
Reynolds, P. A., Sigaroudinia, M., Zardo, G., Wilson, M. B., Benton, G. M., Miller, C. J., Hong, C., Fridlyand, J., Costello, J. F., & Tlsty, T. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604175200 · Cited by 139
Nature or nurture: Let food be your epigenetic medicine in chronic inflammatory disorders
Szic, K. S. V., Ndlovu, ’. N., Haegeman, G., & Berghe, W. V. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.029 · Cited by 151
RUNX3 is multifunctional in carcinogenesis of multiple solid tumors
Chuang, L. S. H., & Ito, Y. (2010) · Oncogene · doi:10.1038/onc.2010.88 · Cited by 149
Epigenetic regulation of signaling pathways in cancer: Role of the histone methyltransferase EZH2
Tsang, D. P., & Cheng, A. S. L. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06447.x · Cited by 148
Regulation of Seed Size by Hypomethylation of Maternal and Paternal Genomes
Xiao, W., Brown, R. C., Lemmon, B. E., Harada, J. J., Goldberg, R. B., & Fischer, R. L. (2006) · PLANT PHYSIOLOGY · doi:10.1104/pp.106.088849 · Cited by 148
Takeshima, H., Yamashita, S., Shimazu, T., Niwa, T., & Ushijima, T. (2009) · Genome Research · doi:10.1101/gr.093310.109 · Cited by 135
PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma
Brugarolas, J. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e3182a102d1 · Cited by 146
The epigenome as a therapeutic target in prostate cancer
Perry, A. S., Watson, R. W. G., Lawler, M., & Hollywood, D. P. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.185 · Cited by 148
Cai, Y., Geutjes, E.-J., de Lint, K., Roepman, P., Bruurs, L., Yu, L.-R., Wang, W., van Blijswijk, J., Mohammad, H., de Rink, I., et al. (2014) · Oncogene · doi:10.1038/onc.2013.178 · Cited by 127
DNA methylation signatures for breast cancer classification and prognosis
Szyf, M. (2012) · Genome Medicine · doi:10.1186/gm325 · Cited by 147
Zhang, W., Wang, X., Yu, Q., Ming, R., & Jiang, J. (2008) · Genome Research · doi:10.1101/gr.078808.108 · Cited by 145
Epigenetic mechanisms and genome stability
Putiri, E. L., & Robertson, K. D. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0017-z · Cited by 147
Connections between epigenetic gene silencing and human disease
Moss, T. J. M., & Wallrath, L. L. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.05.038 · Cited by 147
Polycomb Repressive Complex 2 (PRC2) Restricts Hematopoietic Stem Cell Activity
Majewski, I. J., Blewitt, M. E., de Graaf, C. A., McManus, E. J., Bahlo, M., Hilton, A. A., Hyland, C. D., Smyth, G. K., Corbin, J. E., Metcalf, D., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060093 · Cited by 131
Fujii, S., & Ochiai, A. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00743.x · Cited by 136
Coordinate Regulation of DNA Methylation and H3K27me3 in Mouse Embryonic Stem Cells
Hagarman, J. A., Motley, M. P., Kristjánsdóttir, K., & Soloway, P. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053880 · Cited by 143
Phosphorylation-Dependent Control of Pc2 SUMO E3 Ligase Activity by Its Substrate Protein HIPK2
Roscic, A., Möller, A., Calzado, M. A., Renner, F., Wimmer, V. C., Gresko, E., Lüdi, K. S., & Schmitz, M. L. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.08.004 · Cited by 143
Zardo, G., Ciolfi, A., Vian, L., Starnes, L. M., Billi, M., Racanicchi, S., Maresca, C., Fazi, F., Travaglini, L., Noguera, N., et al. (2012) · Blood · doi:10.1182/blood-2011-08-371344 · Cited by 142
Ikegami, K., Ohgane, J., Tanaka, S., Yagi, S., & Shiota, K. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082741ki · Cited by 144
Stress and the epigenetic landscape: a link to the pathobiology of human diseases?
Johnstone, S. E., & Baylin, S. B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2881 · Cited by 125
Myeloid malignancies: mutations, models and management
Murati, A., Brecqueville, M., Devillier, R., Mozziconacci, M.-J., Gelsi-Boyer, V., & Birnbaum, D. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-304 · Cited by 139
SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells
Koumangoye, R. B., Andl, T., Taubenslag, K. J., Zilberman, S. T., Taylor, C. J., Loomans-Kropp, H. A., & Andl, C. D. (2015) · Molecular Cancer · doi:10.1186/s12943-014-0284-y · Cited by 139
The mutational landscape of chromatin regulatory factors across 4,623 tumor samples
Gonzalez-Perez, A., Jene-Sanz, A., & Lopez-Bigas, N. (2013) · Genome Biology · doi:10.1186/gb-2013-14-9-r106 · Cited by 125
DNA methylation dynamics in cellular commitment and differentiation
Suelves, M., Carrió, E., Núñez-Álvarez, Y., & Peinado, M. A. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw017 · Cited by 112
B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation
Barwick, B. G., Scharer, C. D., Martinez, R. J., Price, M. J., Wein, A. N., Haines, R. R., Bally, A. P. R., Kohlmeier, J. E., & Boss, J. M. (2018) · Nature Communications · doi:10.1038/s41467-018-04234-4 · Cited by 118
Dead Cas Systems: Types, Principles, and Applications
Brezgin, S. A., Kostyusheva, A. P., Kostyushev, D. S., & Chulanov, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236041 · Cited by 140
Li, R., Ong, S. L., Tran, L. M., Jing, Z., Liu, B., Park, S. J., Huang, Z. L., Walser, T. C., Heinrich, E. L., Lee, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57285-y · Cited by 116
Shin, Y. J., & Kim, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030393 · Cited by 136
Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells
Rodriguez, J., Muñoz, M., Vives, L., Frangou, C. G., Groudine, M., & Peinado, M. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810133105 · Cited by 122
The cell biology of DNA methylation in mammals
Prokhortchouk, E., & Defossez, P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.015 · Cited by 137
Burdge, G. C., Hoile, S. P., Uller, T., Thomas, N. A., Gluckman, P. D., Hanson, M. A., & Lillycrop, K. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028282 · Cited by 126
The conserved role of sirtuins in chromatin regulation
Vaquero, A. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082675av · Cited by 117
Isoform‐specific localization of DNMT3A regulates DNA methylation fidelity at bivalent CpG islands
Manzo, M., Wirz, J., Ambrosi, C., Villaseñor, R., Roschitzki, B., & Baubec, T. (2017) · The EMBO Journal · doi:10.15252/embj.201797038 · Cited by 121
A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms
Martin-Subero, J. I., Ammerpohl, O., Bibikova, M., Wickham-Garcia, E., Agirre, X., Alvarez, S., Brüggemann, M., Bug, S., Calasanz, M. J., Deckert, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006986 · Cited by 134
Orzan, F., Pellegatta, S., Poliani, P. L., Pisati, F., Caldera, V., Menghi, F., Kapetis, D., Marras, C., Schiffer, D., & Finocchiaro, G. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01132.x · Cited by 124
Genome-wide identification and analysis of prognostic features in human cancers
Smith, J. C., & Sheltzer, J. M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110569 · Cited by 134
Kanwal, R., & Gupta, S. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00066.2010 · Cited by 134
Palakurthy, R. K., Wajapeyee, N., Santra, M. K., Gazin, C., Lin, L., Gobeil, S., & Green, M. R. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.009 · Cited by 122
Sirtuin‐dependent epigenetic regulation in the maintenance of genome integrity
Bosch‐Presegué, L., & Vaquero, A. (2015) · The FEBS Journal · doi:10.1111/febs.13053 · Cited by 132
The role of methyl-binding proteins in chromatin organization and epigenome maintenance
Fournier, A., Sasai, N., Nakao, M., & Defossez, P. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr040 · Cited by 135
Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2–ERα–GREB1 Transcriptional Axis
Wu, Y., Zhang, Z., Cenciarini, M. E., Proietti, C. J., Amasino, M., Hong, T., Yang, M., Liao, Y., Chiang, H.-C., Kaklamani, V., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1327 · Cited by 133
Epigenetics in ovarian cancer: premise, properties, and perspectives
Yang, Q., Yang, Y., Zhou, N., Tang, K., Lau, W. B., Lau, B., Wang, W., Xu, L., Yang, Z., Huang, S., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0855-4 · Cited by 133
Herrera-Merchan, A., Arranz, L., Ligos, J., de Molina, A., Domínguez, O., & González, S. (2012) · Nature Communications · doi:10.1038/ncomms1623 · Cited by 141
RetractedCrosstalk among Epigenetic Pathways Regulates Neurogenesis
Jobe, E. M., McQuate, A. L., & Zhao, X. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00059 · Cited by 123
Epigenetic remodeling during arsenical-induced malignant transformation
Jensen, T. J., Novák, P., Eblin, K. E., Gandolfi, A. J., & Futscher, B. W. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn102 · Cited by 133
Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b
James, S. R., Link, P. A., & Karpf, A. R. (2006) · Oncogene · doi:10.1038/sj.onc.1209678 · Cited by 133
A Dynamic Reciprocal RBR-PRC2 Regulatory Circuit Controls Arabidopsis Gametophyte Development
Johnston, A. J., Matveeva, E., Kirioukhova, O., Grossniklaus, U., & Gruissem, W. (2008) · Current Biology · doi:10.1016/j.cub.2008.09.026 · Cited by 132
Clements, E. G., Mohammad, H. P., Leadem, B. R., Easwaran, H., Cai, Y., Van Neste, L., & Baylin, S. B. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks031 · Cited by 121
Interpretation of Developmental Signaling at Chromatin: The Polycomb Perspective
Sawarkar, R., & Paro, R. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.10.012 · Cited by 130
Bodega, B., Ramírez, G. D. C., Grasser, F., Cheli, S., Brunelli, S., Mora, M., Meneveri, R., Marozzi, A., Müller, S., Battaglioli, E., et al. (2009) · BMC Biology · doi:10.1186/1741-7007-7-41 · Cited by 130
King, A., Huang, K. Y., Rubbi, L., Liu, S., Wang, C., Wang, Y., Pellegrini, M. A., & Fan, G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.083 · Cited by 133
Pepin, M. E., Ha, C., Crossman, D. K., Litovsky, S. H., Varambally, S., Barchue, J. P., Pamboukian, S. V., Diakos, N., Drakos, S. G., Pogwizd, S. M., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0104-x · Cited by 130
DNA hypermethylation during tuberculosis dampens host immune responsiveness
DiNardo, A. R., Rajapakshe, K., Nishiguchi, T., Mtetwa, G., Dlamini, Q., Kahari, J., Mahapatra, S., Kay, A., Gugu, M., Mace, E., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134622 · Cited by 130
Targeting EZH2 and PRC2 dependence as novel anticancer therapy
Xu, B., Konze, K. D., Jin, J., & Wang, G. G. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.001 · Cited by 124
BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV
Paschos, K., Parker, G. A., Watanatanasup, E., White, R. E., & Allday, M. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks391 · Cited by 128
Wu, L.-P., Wang, X., Li, L., Zhao, Y., Lu, S., Yu, Y., Zhou, W., Liu, X., Yang, J., Zheng, Z., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01516-07 · Cited by 122
Jia, J., Li, F., Tang, X., Xu, S., Gao, Y., Shi, Q., Guo, W., Wang, X., He, D., & Guo, P. (2016) · Oncotarget · doi:10.18632/oncotarget.9350 · Cited by 128
The Epigenome in Neurodevelopmental Disorders
Reichard, J., & Zimmer‐Bensch, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.776809 · Cited by 127
McGarvey, K. M., Greene, E., Fahrner, J. A., Jenuwein, T., & Baylin, S. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2029 · Cited by 115
Rizo, A., Vellenga, E., de Haan, G., & Schuringa, J. J. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl175 · Cited by 132
Polycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic Implications
Wang, W. T., Qin, J., Voruganti, S., Nag, S. A., Zhou, J., & Zhang, R. (2015) · Medicinal Research Reviews · doi:10.1002/med.21358 · Cited by 126
Atonal homolog 1 Is a Tumor Suppressor Gene
Bossuyt, W., Kazanjian, A. A., Geest, N. D., Kelst, S. V., Hertogh, G. D., Geboes, K. J., Boivin, G. P., Luciani, J., Fuks, F., Chuah, M., et al. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000039 · Cited by 126
Self-citationEpigenetics in pain and analgesia: An imminent research field
Doehring, A., Geisslinger, G., & Lötsch, J. (2011) · European Journal of Pain · doi:10.1016/j.ejpain.2010.06.004 · Cited by 121
Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma
Cardoso, L., Stevenson, M., & Thakker, R. V. (2017) · Human Mutation · doi:10.1002/humu.23337 · Cited by 126
Effects of 5-Aza-2′-deoxycytidine (decitabine) on gene expression
Seelan, R. S., Mukhopadhyay, P., Pisano, M., & Greene, R. M. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1437446 · Cited by 126
Hayden, A. L., Johnson, P., Packham, G. K., & Crabb, S. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0982-0 · Cited by 125
Fiskus, W. C., Pranpat, M., Balasis, M. E., Herger, B. E., Rao, R., Chinnaiyan, A. M., Atadja, P. W., & Bhalla, K. N. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0418 · Cited by 130
Effect of maternal diet on the epigenome: implications for human metabolic disease
Lillycrop, K. A. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665110004027 · Cited by 108
DNMT3B Functions: Novel Insights From Human Disease
Gagliardi, M., Strazzullo, M., & Matarazzo, M. R. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00140 · Cited by 126
Coward, W. R., Feghali‐Bostwick, C. A., Jenkins, G., Knox, A. J., & Pang, L. (2014) · The FASEB Journal · doi:10.1096/fj.13-241760 · Cited by 117
Epigenetic Modifications in Breast Cancer and Their Role in Personalized Medicine
Stefánsson, Ó. A., & Esteller, M. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.04.033 · Cited by 125
Self-citationCancer Epigenetics: A Brief Review
Virani, S., Colacino, J. A., Kim, J. H., & Rozek, L. S. (2012) · ILAR Journal · doi:10.1093/ilar.53.3-4.359 · Cited by 123
Coit, P., Dozmorov, M. G., Merrill, J. T., McCune, W. J., Maksimowicz‐McKinnon, K., Wren, J. D., & Sawalha, A. H. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39720 · Cited by 124
Lü, X., Fong, K.-W., Gritsina, G., Wang, F., Baca, S. C., Brea, L. T., Berchuck, J. E., Spisák, S., Ross, J., Morrissey, C. M., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01045-8 · Cited by 124
Metadata
- Authors
- Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y., & Fuks, F.
- Affiliations
- Université Libre de Bruxelles (BE)
- Spanish National Cancer Research Centre (ES)
- KU Leuven (BE)
- Corresponding author
- Fuks, François
- ORCID
- Venue
- Nature
- Published
- 2005-12-14
- Volume
- 439
- Issue
- 7078
- Pages
- 871-874
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2053421436
- Cited by
- 2,204
- References
- 27
- Citations by year
- 2026: 32 · 2025: 52 · 2024: 60 · 2023: 72 · 2022: 89 · 2021: 110 · 2020: 95 · 2019: 94 · 2018: 95 · 2017: 119 · 2016: 151 · 2015: 134 · 2014: 128 · 2013: 135 · 2012: 164
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-04-12)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Fédération Wallonie-Bruxelles
- Fondation pour la Recherche Médicale
- Ministerio de Economía y Competitividad
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- EZH2, Polycomb group proteins, DNA methylation, DNA methyltransferases, polycomb repressive complex 2, epigenetic silencing, chromatin repression, promoter methylation, protein-protein interaction
- MeSH terms
- Enhancer of Zeste Homolog 2 Protein, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, HeLa Cells, Humans, Promoter Regions, Genetic, Protein Binding, Repressor Proteins, Substrate Specificity, Transcription Factors, CpG Islands, DNA Methylation, Gene Silencing, Epigenesis, Genetic, Chromatin Immunoprecipitation, Polycomb-Group Proteins, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.